VBI Vaccines Inc.
VBIV · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 702.4% | 71.5% | -40.5% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -67% | -942.1% | -1,606.8% | -764.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -953.5% | -9,798.5% | -9,954.7% | -3,888.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,069.3% | -13,026.9% | -11,513.5% | -4,456.7% |
| EPS Diluted | -5.96 | -16.37 | -8.55 | -6.5 |
| % Growth | 63.6% | -91.5% | -31.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |